文献速递冠心病外科瓣膜外科

乳酸林格液与Plasma-Lyte A作为del Nido心脏停搏液基础液的比较:一项前瞻性随机试验

Comparison of lactated Ringer's solution and Plasma-Lyte A as a base solution for del Nido cardioplegia: a prospective randomized trial.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

主要终点术后24小时肌钙蛋白-T两组相似(0.482 vs 0.524 ng/ml;P=0.464),其他心脏标志物及临床结局均无显著差异。结果提示乳酸林格液可作为Plasma-Lyte A的替代基础液。

要点

  • 术后24小时肌钙蛋白-T乳酸林格液组0.482 ng/ml vs Plasma-Lyte A组0.524 ng/ml,P=0.464。
  • 乳酸林格液组停搏液pH较低(7.228 vs 7.246;P=0.005),钙水平较高(0.908 vs 0.358 mmol/l;P<0.001)。
  • 室颤、左室射血分数、正性肌力药/血管加压药需求、主动脉内球囊反搏、ICU停留、住院时间、房颤、红细胞输注及并发症均无显著差异。

核心结论

  • 结果提示乳酸林格液可作为Plasma-Lyte A的替代基础液用于del Nido心脏停搏液,心肌保护与临床结局相似。

研究设计与样本

  • 前瞻性随机对照试验,纳入首次择期成人获得性心脏病手术患者,包括孤立冠状动脉旁路移植术、孤立瓣膜手术、联合瓣膜手术或冠状动脉旁路移植联合瓣膜手术,随机分为乳酸林格液组(n=100)与Plasma-Lyte A组(n=100)。

主要发现

  • 两组年龄、合并症、胸外科医师协会风险评分及手术类型无显著差异。
  • 主要终点术后24小时肌钙蛋白-T两组相似(0.482 vs 0.524 ng/ml;P=0.464),其他心脏标志物在所有时间点也相似。
  • 乳酸林格液组停搏液pH较低(7.228 vs 7.246;P=0.005),钙水平较高(0.908 vs 0.358 mmol/l;P<0.001)。
  • 室颤、左室射血分数、正性肌力药/血管加压药需求、主动脉内球囊反搏支持、ICU停留、住院时间、房颤、红细胞输注及并发症等临床结局无显著差异。

临床怎么用

  • 原文结论提示乳酸林格液可作为Plasma-Lyte A的替代基础液用于del Nido心脏停搏液。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The use of del Nido cardioplegia has been increasing in popularity for adult cardiac surgery. However, the base solution, Plasma-Lyte A, is not always available in many countries. This prospective randomized controlled trial evaluated myocardial preservation and clinical outcomes when using lactated Ringer's solution (LRS) compared to Plasma-Lyte A as a base solution for del Nido cardioplegia. METHODS: Adult patients undergoing first-time elective cardiac surgery for acquired heart disease, including isolated coronary artery bypass grafting, isolated valve surgery, combined valve surgery or concomitant coronary artery bypass grafting and valve surgery were randomized to receive either LRS (n = 100) or Plasma-Lyte A (n = 100). RESULTS: There were no significant differences between the 2 groups in terms of age, comorbidities, Society of Thoracic Surgeons risk score and type of procedures. The primary outcome, postoperative troponin-T at 24 h, was similar in both groups (0.482 vs 0.524 ng/ml; P = 0.464). Other cardiac markers were also similar at all time points. The LRS group had a lower pH (7.228 vs 7.246; P = 0.005) and higher calcium levels (0.908 vs 0.358 mmol/l; P < 0.001) in the delivered cardioplegia, but there were no significant differences in clinical outcomes, such as ventricular fibrillation, left ventricular ejection fraction, inotrope/vasopressor requirement, intra-aortic balloon pump support, intensive care unit stay, hospital stay, atrial fibrillation, red cell transfusion and complications. CONCLUSIONS: The results suggest that LRS can be used as an alternative to Plasma-Lyte A as the base solution for del Nido cardioplegia, with similar myocardial preservation and clinical outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kantathut N, Krathong P, Khajarern S, et al. Comparison of lactated Ringer's solution and Plasma-Lyte A as a base solution for del Nido cardioplegia: a prospective randomized trial. Eur J Cardiothorac Surg. 2024. PMID: 38244592. doi:10.1093/ejcts/ezae018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。